158 related articles for article (PubMed ID: 31818158)
21. Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study.
Jeong C; Kwon HI; Baek H; Kim HS; Lim DJ; Baek KH; Ha J; Kang MI
Endocrinol Metab (Seoul); 2020 Dec; 35(4):925-932. PubMed ID: 33297604
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis.
Diao Z; Liu X; Qian L; Liu J; Liu S; Liu W
Int J Hyperthermia; 2016 Sep; 32(6):614-22. PubMed ID: 27329009
[TBL] [Abstract][Full Text] [Related]
23. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Chai HH; Yu MA
Int J Hyperthermia; 2021; 38(1):1023-1030. PubMed ID: 34219596
[TBL] [Abstract][Full Text] [Related]
24. [Re-operation treatment in uremic patients complicated with persistent secondary hyperparathyroidism after parathyroidectomy with autotransplantation].
Bo SJ; Xu XF; Qiu CY; Wang TT; Ning YD; Li HY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(2):142-147. PubMed ID: 29757564
[No Abstract] [Full Text] [Related]
25. Long-Term Effect of Microwave Ablation on Patients Undergoing Hemodialysis for Moderate Secondary Hyperparathyroidism: A Retrospective Cohort Study.
Li D; Wang G; Chen X; Guo W; Huang H; Diao Z; Liu W
J Ultrasound Med; 2021 Nov; 40(11):2497-2505. PubMed ID: 33484485
[TBL] [Abstract][Full Text] [Related]
26. Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
Wei Y; Peng L; Li Y; Zhao ZL; Yu MA
Korean J Radiol; 2020 May; 21(5):572-581. PubMed ID: 32323502
[TBL] [Abstract][Full Text] [Related]
27. Primary and secondary hyperparathyroidism present different expressions of calcium-sensing receptor.
Li X; Lu Y; Zhang L; Song A; Zhang H; Pang B; Liu J; Sun X; Ji H; Huang L; Yang M
BMC Surg; 2023 Feb; 23(1):31. PubMed ID: 36755240
[TBL] [Abstract][Full Text] [Related]
28. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism.
Liu F; Yu X; Liu Z; Qiao Z; Dou J; Cheng Z; Han Z; Yu J; Liang P
Int J Hyperthermia; 2019; 36(1):835-840. PubMed ID: 31452422
[No Abstract] [Full Text] [Related]
29. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: A meta-analysis.
Gong L; Tang W; Lu J; Xu W
Int J Surg; 2019 Oct; 70():13-18. PubMed ID: 31404676
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-guided thermal ablation for hyperparathyroidism: current status and prospects.
Chen Z; Cheng L; Zhang W; He W
Int J Hyperthermia; 2022; 39(1):466-474. PubMed ID: 35271788
[TBL] [Abstract][Full Text] [Related]
31. Role of Sonazoid-based contrast-enhanced ultrasonography in the microwave ablation of primary hyperparathyroidism.
Zhou ZB; Xue YE; Yao YW; Zhang XT; Zhang MH; Yang DX; Xie JH
Int J Hyperthermia; 2022; 39(1):155-161. PubMed ID: 35000496
[TBL] [Abstract][Full Text] [Related]
32. Feasibility and safety of ultrasound-guided percutaneous microwave ablation for tertiary hyperparathyroidism.
Hu Z; Han E; Chen W; Chen J; Chen W; Guo R
Int J Hyperthermia; 2019; 36(1):1129-1136. PubMed ID: 31744350
[No Abstract] [Full Text] [Related]
33. A study on the causes of operative failures after microwave ablation for primary hyperparathyroidism.
Ying W; Zhen-Long Z; Xiao-Jing C; Li-Li P; Yan L; Ming-An Y
Eur Radiol; 2021 Sep; 31(9):6522-6530. PubMed ID: 33651201
[TBL] [Abstract][Full Text] [Related]
34. Risk factors influencing cure of ultrasound-guided microwave ablation for primary hyperparathyroidism.
Liu F; Zang L; Liu Y; Yu X; Cheng Z; Han Z; Yu J; Liang P
Int J Hyperthermia; 2022; 39(1):258-264. PubMed ID: 35109732
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of efficacy of ultrasound-guided microwave ablation in primary hyperparathyroidism.
Zhang M; Gao Y; Zhang X; Ding Z; Wang X; Jiang W; Zhao C
J Clin Ultrasound; 2022 Feb; 50(2):227-235. PubMed ID: 34984687
[TBL] [Abstract][Full Text] [Related]
36. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study.
Fan BQ; He XW; Chen HH; Zhang WM; Tang W
Eur Radiol; 2019 Oct; 29(10):5607-5616. PubMed ID: 30888479
[TBL] [Abstract][Full Text] [Related]
37. Postsurgical Evaluation of Secondary Nephrogenic Hyperparathyroidism.
Mi JP; Liao ZP; Pei XF; Hong HY; Fan YP
Curr Med Sci; 2019 Apr; 39(2):259-264. PubMed ID: 31016519
[TBL] [Abstract][Full Text] [Related]
38. Microwave ablation as an efficient therapy for primary hyperparathyroidism: Efficacy and predictors of treatment success.
Erturk MS; Cekic B; Sarı IK; Pamuk BO
Int J Clin Pract; 2021 Oct; 75(10):e14580. PubMed ID: 34185346
[TBL] [Abstract][Full Text] [Related]
39. US-guided Microwave Ablation of Hyperplastic Parathyroid Glands: Safety and Efficacy in Patients with End-Stage Renal Disease-A Pilot Study.
Zhuo L; Peng LL; Zhang YM; Xu ZH; Zou GM; Wang X; Li WG; Lu MD; Yu MA
Radiology; 2017 Feb; 282(2):576-584. PubMed ID: 27552557
[TBL] [Abstract][Full Text] [Related]
40. US-Guided Percutaneous Microwave Ablation for Primary Hyperparathyroidism with Parathyroid Nodules: Feasibility and Safety Study.
Liu C; Wu B; Huang P; Ding Q; Xiao L; Zhang M; Zhou J
J Vasc Interv Radiol; 2016 Jun; 27(6):867-75. PubMed ID: 27106734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
